Manuel Mohr

Company: D2B3

Job title: Co-Founder & Chief Executive Officer

Seminars:

Blood Brain Barrier Relaxers as a Differentiated Approach to Systemic CNS Delivery of Oligonucleotides 12:00 pm

Overview of the underlying technology and its mechanism of action Presentation of key in vivo data demonstrating enhanced CNS delivery Comparison of this approach with existing CNS oligonucleotide delivery strategiesRead more

day: Conference Day One